DAVID L PATTERSON
Allopathic & Osteopathic Physicians|Allergy & Immunology NOBLESVILLE, IN NPI 1922001007
Browse related groups: Allopathic & Osteopathic Physicians|Allergy & Immunology IN ADMA BioManufacturing LLC All categories
General Payments — all program years on this page
$283,896.63
- Category: General Payments
- Program years: PY2018–2024
- Record count: 758
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $7,141.91 across 51 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $2,500.00 | 1 |
| Consulting Fee | $2,153.34 | 2 |
| Food and Beverage | $1,446.59 | 46 |
| Travel and Lodging | $1,041.98 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ADMA BioManufacturing LLC | $3,242.35 | 4 |
| Regeneron Healthcare Solutions, Inc. | $2,132.00 | 1 |
| Consortium of Independent Immunology Clinics, LLC | $765.97 | 2 |
| GlaxoSmithKline, LLC. | $304.78 | 11 |
| Acerta Pharma LLC | $190.35 | 10 |
| Takeda Pharmaceuticals U.S.A., Inc. | $89.49 | 3 |
| Pharming Healthcare, Inc. | $87.11 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $63.06 | 4 |
| Octapharma USA, Inc. | $58.10 | 2 |
| Grifols USA, LLC | $46.96 | 2 |
| GENZYME CORPORATION | $32.99 | 1 |
| X4 Pharmaceuticals, Inc. | $20.95 | 1 |
| CSL Behring | $20.42 | 1 |
| Amgen Inc. | $18.71 | 1 |
| PFIZER INC. | $18.71 | 1 |
| Blueprint Medicines Corporation | $17.88 | 1 |
| Dermavant Sciences, Inc. | $17.72 | 1 |
| Phadia US Inc. | $14.36 | 1 |
By program year
Records — PY2024 (51)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.